Technology · 1 sources covering this

RenaissThera is designing oral drugs for obesity and type 2 diabetes

The Bengaluru-based company uses AI-led discovery to search for small molecules that act on the same receptors as injectable GLP-1 drugs, aiming for a cheaper alternative.

Share:WhatsApp X Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

YourStory·2h ago
RenaissThera is designing oral drugs for obesity and type 2 diabetes
The Bengaluru-based company uses AI-led discovery to search for small molecules that act on the same receptors as injectable GLP-1 drugs, aiming for a cheaper alternative.
Read at YourStory →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/3ccfc683001ad1343338f8ded27519e4455afb5f"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="RenaissThera is designing oral drugs for obesity and type 2 diabetes"></iframe>

RenaissThera is designing oral drugs for obesity and type 2 diabetes

How 1 sources are covering this

RenaissThera is designing oral drugs for obesity and type 2 diabetes

More from Technology

Google Pay gets an AI upgrade in India: New 'Ask Google Pay' feature helps you track your spending

European Union aims for seven AI gigafactories with €10 billion plan in race with US, China

How StockGro Is Building An Intelligence Layer For India’s Next 100 Mn Investors

Inside HomeLane’s Decade-Long Quest To Organise Home Interiors And Build A ₹1,000 Cr Business

Reader

Trust & legal

Across the network

How 1 sources are covering this

RenaissThera is designing oral drugs for obesity and type 2 diabetes

More from Technology

Google Pay gets an AI upgrade in India: New 'Ask Google Pay' feature helps you track your spending

European Union aims for seven AI gigafactories with €10 billion plan in race with US, China

How StockGro Is Building An Intelligence Layer For India’s Next 100 Mn Investors

Inside HomeLane&#8217;s Decade-Long Quest To Organise Home Interiors And Build A ₹1,000 Cr Business

Reader

Trust & legal

Across the network

Inside HomeLane’s Decade-Long Quest To Organise Home Interiors And Build A ₹1,000 Cr Business